Currently, all locations in Maryland and Virginia are fully booked.
Retail giant Target has partnered with CVS to bring Covid-19 vaccines in more than 600 stores across 17 states nationwide, including Virginia and Maryland. Target announced this partnership on Wednesday.
We're partnering with @cvspharmacy to offer eligible guests the COVID-19 vaccine, now available at more than 600 Target stores. And there's more on the way — get the details here: https://t.co/InbZFAhlYg pic.twitter.com/EkjHoE55BU— Target News (@TargetNews) March 10, 2021
As of Wednesday, all the locations in the cities of Maryland and Virginia are fully booked, as displayed on the CVS site.
Besides Maryland and Virginia, other states include Alabama, Arizona, California, Connecticut, Florida, Hawaii, Louisiana, Massachusetts, New Jersey, New York, Ohio, Pennsylvania, Rhode Island, South Carolina, and Texas. The availability of the type of vaccines will depend on the store location.
The vaccine will be offered to everyone, including all Target and CVS employees, following the local eligibility guidelines.
“Target already supports CVS-administered vaccinations each year for the flu, shingles, and pneumonia, and we’ll continue to partner closely as they administer the vaccine while following state and federal guidelines,” announced the company in a news release. “We’re also making fitting rooms available to CVS at select stores to host appointments.”
Appointments for vaccination can be booked from cvs.com or CVS Pharmacy app. In case of limited internet accessibility, customer service via phone is available at 800-746-7287 to check vaccine eligibility and book an appointment.
The company also said of providing more support in the coming months. "That'll mean continuing to work with CVS to offer vaccines to guests and team members within stores," mentioned Target in the release.
Currently, 9.78% of the nation's population is fully vaccinated, and about 18.4% have received at least one COVID-19 shot.
Have you received the COVID-19 vaccine? Let us know in the comments.